Physician profile
Derrick A Pierce
NPI 1992997969
$3,411.98
in general payments reported to CMS, 2019-2025
15 companies · $614 in 2025
The $614 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $106 · 2021: $647 · 2022: $245 · 2023: $687 · 2024: $771 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053 · Entertainment: $18.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.12 |
| Entertainment | $18.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,078.59 | 2022-2025 | Infuse, Infuse Multifocal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $736.17 | 2019-2021 | |
| Glaukos Corporation | $499.93 | 2021-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Coopervision INC. | $357.05 | 2019-2024 | Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $137.42 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Alcon Vision LLC | $127.25 | 2023-2025 | Total30, Precision7 |
| Tarsus Pharmaceuticals, INC. | $117.92 | 2024 | Xdemvy |
| Lombart Brothers, INC. | $81.28 | 2024-2025 | Opd-III |
| Johnson & Johnson Vision Care, INC. | $68.43 | 2022-2024 | Acuvue |
| Carl Zeiss Meditec USA, INC. | $67.05 | 2023 | Clarus |
| Optos, INC. | $44.30 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $42.64 | 2024 | Tearcare System |
| Abbvie INC. | $20.64 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $13.91 | 2024 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.